Surmodics | SRDX - الأصول





الأصول تغيير تاريخ
Abbott USD 110.43B 23.72B 2026-03
Align Technology USD 6.31B 80.48M 2026-03
Anika Therapeutics USD 179.39M 10.88M 2026-03
Arrowhead Research USD 1.6B 218.89M 2025-12
Artivion USD 884.8M 27.13M 2025-12
Baxter International USD 19.85B 209M 2026-03
Boston Scientific USD 44.35B 678M 2026-03
EDAP TMS EUR 61.46M 6.88M 2025-09
Edwards Lifesciences USD 13.7B 425M 2025-12
Haemonetics USD 2.49B 48.73M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
J&J USD 200.89B 1.68B 2026-03
Merit Medical Systems USD 2.72B 33.36M 2026-03
Mesa Laboratories USD 434.85M 4.5M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Option Care Health USD 3.38B 75.67M 2026-03
Stryker USD 46.29B 1.55B 2026-03
Surmodics USD 169.82M 8.74M 2025-06
Trinity Biotech USD 103.71M 4.08M 2025-09